MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 139 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,389,000 | -61.5% | 775,571 | -49.1% | 0.93% | -56.5% |
| Q4 2016 | $6,212,000 | -47.7% | 1,522,529 | -18.6% | 2.13% | -40.3% |
| Q3 2016 | $11,879,000 | -1.8% | 1,870,777 | -16.6% | 3.57% | -20.8% |
| Q2 2016 | $12,096,000 | -37.9% | 2,244,080 | -3.6% | 4.51% | -29.3% |
| Q1 2016 | $19,482,000 | +11.5% | 2,327,599 | +5.2% | 6.38% | +37.7% |
| Q4 2015 | $17,474,000 | -12.9% | 2,211,880 | -6.2% | 4.63% | -20.9% |
| Q3 2015 | $20,063,000 | -22.7% | 2,357,558 | +12.3% | 5.86% | -14.0% |
| Q2 2015 | $25,968,000 | +13.1% | 2,100,140 | +8.7% | 6.81% | +10.8% |
| Q1 2015 | $22,951,000 | +30.2% | 1,931,872 | +23.8% | 6.14% | +30.4% |
| Q4 2014 | $17,634,000 | – | 1,560,530 | – | 4.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,442,159 | $15,508,000 | 3.96% |
| Consonance Capital Management LP | 5,950,225 | $37,784,000 | 3.64% |
| Lagoda Investment Management, L.P. | 1,870,777 | $11,879,000 | 3.57% |
| ALTFEST L J & CO INC | 39,490 | $1,508,000 | 1.00% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $525,000 | 0.49% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8,894,008 | $56,477,000 | 0.46% |
| Cannell & Co. | 1,611,678 | $10,234,000 | 0.37% |
| Portolan Capital Management | 412,189 | $2,617,000 | 0.36% |
| Virtus ETF Advisers LLC | 100,090 | $636,000 | 0.31% |
| INDUS CAPITAL PARTNERS, LLC | 500,000 | $3,175,000 | 0.30% |